Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE CORSIN : revenue, balance sheet and financial ratios

PHARMACIE CORSIN is a French company founded 17 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in RILLIEUX-LA-PAPE (69140), this company of category PME shows in 2016 a revenue of 978 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - PHARMACIE CORSIN (SIREN 505186791)
Kennzahl 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Umsatz N/C N/C N/C N/C N/C N/C N/C N/C N/C 977 867 €
Nettoergebnis 140 462 € 92 570 € 152 341 € 209 716 € 146 969 € 107 006 € 52 088 € 76 980 € 87 954 € 82 301 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C 112 834 €
Nettomarge N/C N/C N/C N/C N/C N/C N/C N/C N/C 8.4%

Umsatz und Gewinn- und Verlustrechnung

In 2025, PHARMACIE CORSIN generates positive net income of 140 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 82 k€ -> 140 k€.

Nettoergebnis (2025) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

140 462 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 62%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 54%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Verschuldungsgrad (2025) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

61.922%

Finanzielle Autonomie (2025) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

53.835%

Anlagenaltersquote (2025) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

21.2%

Entwicklung der Solvenzkennzahlen
PHARMACIE CORSIN

Positionnement sectoriel

Debt ratio
61.92 2025
2023
2024
2025
Q1: 13.7
Méd: 49.79
Q3: 129.09
Average

In 2025, the debt ratio of PHARMACIE CORSIN (61.92) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
53.84% 2025
2023
2024
2025
Q1: 33.42%
Méd: 53.72%
Q3: 72.08%
Good

In 2025, the financial autonomy of PHARMACIE CORSIN (53.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 228.30. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2025) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

228.301

Entwicklung der Liquiditätskennzahlen
PHARMACIE CORSIN

Positionnement sectoriel

Liquidity ratio
228.3 2025
2023
2024
2025
Q1: 131.03
Méd: 182.25
Q3: 258.64
Good +9 pts über 3 Jahre

In 2025, the liquidity ratio of PHARMACIE CORSIN (228.30) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Umlaufvermögensbedarf und Zahlungsfristen

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operatives Working Capital (2025) ?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Formel
Stocks + Créances clients - Dettes fournisseurs
Interpretation
Negativ = freigesetzte Liquidität
Positiv = Finanzierungsbedarf

0 €

Kundenforderungen (2025) ?
Kundenforderungen (Tage)
Definition
Durchschnittliche Zahlungsfrist für Kunden.
Formel
(Kundenforderungen / Umsatz inkl. MwSt.) x 360
Interpretation
< 45j : Gut
45-60j : Durchschnitt
> 60j : Lang

0 j

Lieferantenverbindlichkeiten (2025) ?
Lieferantenverbindlichkeiten (Tage)
Definition
Durchschnittliche Zahlungsfrist von Lieferanten.
Formel
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität

0 j

Lagerumschlag (2025) ?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag

0 j

Entwicklung des Working Capital und der Zahlungsfristen
PHARMACIE CORSIN

Positionnement de PHARMACIE CORSIN dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE CORSIN is estimated at 2 231 255 € (range 1 514 140€ - 3 501 147€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1514k€ 2231k€ 3501k€
2 231 255 € Range: 1 514 140€ - 3 501 147€
NAF 5 année 2025

Valuation method used

Net Income Multiple
140 462 € × 15.9x = 2 231 256 €
Range: 1 514 141€ - 3 501 147€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE CORSIN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE CORSIN

What is the revenue of PHARMACIE CORSIN ?

The revenue of PHARMACIE CORSIN in 2016 is 978 k€.

Is PHARMACIE CORSIN profitable?

Yes, PHARMACIE CORSIN generated a net profit of 140 k€ in 2025.

Where is the headquarters of PHARMACIE CORSIN ?

The headquarters of PHARMACIE CORSIN is located in RILLIEUX-LA-PAPE (69140), in the department Rhone.

Where to find the tax return of PHARMACIE CORSIN ?

The tax return of PHARMACIE CORSIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE CORSIN operate?

PHARMACIE CORSIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.